Sign In

Michael Shih

VP, Corporate Development at Kite Pharma

Michael Shih is a seasoned executive in the pharmaceutical industry with extensive experience in corporate development, business development, and licensing. He currently serves as the VP of Corporate Development at Kite Pharma, a position he has held since December 2022.1

Career Highlights

Current Role:: At Kite Pharma, Shih is responsible for licensing, collaborations, mergers and acquisitions (M&A), and other business development opportunities for the company's portfolio.1

Previous Positions::

  • SVP, Head of Business Development at Biogen (July 2021 - December 2022)
  • VP, Head of Global Transactions at Sanofi (January 2019 - July 2021)
  • Head of Sanofi Genzyme Transactions (April 2018 - December 2018)
  • Vice President of Business Development at Epizyme (September 2014 - September 2015)
  • Senior Director and Director of Business Development at Eisai US (July 2007 - March 2012)

Education

Shih has a strong educational background in both science and law:

  • J.D. from Fordham University School of Law (currently retired from law practice)
  • M.S. in Biology from the University of Illinois at Urbana-Champaign
  • B.S. in Molecular Biology from Cornell University1

Professional Expertise

Throughout his career, Michael Shih has demonstrated expertise in:

  • Strategic business development
  • Licensing and collaborations
  • Mergers and acquisitions
  • Alliance management
  • Negotiation and execution of global business development transactions

His diverse experience across multiple pharmaceutical companies has given him a broad perspective on the industry and a strong foundation in corporate strategy and business development.1

Related Questions

What are some of the key projects Michael Shih has led at Kite Pharma?
How did Michael Shih's role at Biogen differ from his role at Kite Pharma?
What is Michael Shih's educational background and how has it influenced his career?
Can you provide examples of successful collaborations Michael Shih has managed?
What are Michael Shih's main responsibilities in corporate development at Kite Pharma?
Michael Shih
Michael Shih, photo 1
Michael Shih, photo 2
Add to my network

Experience

VP, Corporate Development at Kite Pharma (December 2022 - Present)
SVP, Head of Business Development at Biogen (July 2021 - December 2022); VP, Head of Global Transactions at Sanofi (January 2019 - July 2021); Head of Sanofi Genzyme Transactions (April 2018 - December 2018)

Education

J.D. in Law from Fordham University School of Law; M.S. in Biology from University of Illinois at Urbana-Champaign; B.S. in Molecular Biology from Cornell University

Location

New York City Metropolitan Area